• Australia & New Zealand

    Since 1993, Quintiles Australia and New Zealand have provided fully integrated services for Phase II-IV clinical studies to the pharmaceutical industry. These locations are part of our infrastructure that enables the transfer of best practices around the globe.
  • Australia and New Zealand Perspectives

  • Quintiles

  • Quintiles

    A Blueprint for Clinical and Commercial Convergence

    This paper examines the obstacles to achieving the convergence of clinical development and commercialization, and offers suggestions on how to develop and deploy a “Clinical-Commercial Product Blueprint” to compete in the New Health.  Read white paper